QVT Score In NSCLC Immunotherapy: A New Imaging Biomarker For Prognosis And Early Response Monitoring
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A new imaging biomarker, known as the QVT score, is being reported in the context of nsclc immunotherapy. This biomarker may be used for prognosis and early response monitoring. The QVT score's role and potential impact in this area are being discussed.